Bruker BRKR Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Thermo Fisher ScientificTMO

$6.12B+43.2%

DanaherDHR

$6.52B+15.8%

TEC

Bio-TechneTECH

$21.67M+38.4%

WAT

Waters CorporationWAT

$158M-28.1%

Agilent TechnologiesA

$496M-7.3%

908 DevicesMASS

$15K—

FAQ

What is Bruker's other non-current liabilities?

Bruker (BRKR) reported other non-current liabilities of $597.7M in Q2 2026.

How has Bruker's other non-current liabilities changed year-over-year?

Bruker's other non-current liabilities decreased by 19.9% year-over-year, from $746M to $597.7M.

What is the long-term trend for Bruker's other non-current liabilities?

Over 5 years (2020 to 2025), Bruker's other non-current liabilities has grown at a 27.8% compound annual growth rate (CAGR), from $176.1M to $599.4M.

What does other non-current liabilities mean?

Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.